Osteopetrosis--multiple pathways for the interception of osteoclast function
- PMID: 3304355
Osteopetrosis--multiple pathways for the interception of osteoclast function
Abstract
Osteopetrosis is a metabolic bone disease inherited in a number of species including human beings and characterized by a generalized increase in skeletal density detected radiographically. This condition results primarily from reduced osteoclast function which produces partial or complete absence of marrow spaces, a variable compensatory hepatosplenomegaly, interferences with tooth eruption and certain neurological complications. Experimental investigations of some mutations have shown that restoration of bone resorption and recovery from the disease follow bone marrow transplantation. These data indicate that in these mutations, including some children, the defect is intrinsic to osteoclasts or their stem cells. In other mutations in animals and children, bone marrow transplants do not restore bone resorption and the defect is believed to be one of local environmental products or signals whose importance in cell differentiation and regulation is becoming increasingly appreciated. These data, reviewed with respect to the emerging cell biology of the osteoclast, indicate that osteopetrotic mutations have much to teach us about the regulation of bone metabolism.
Similar articles
-
Osteoclast biology: lessons from mammalian mutations.Am J Med Genet. 1989 Sep;34(1):43-54. doi: 10.1002/ajmg.1320340110. Am J Med Genet. 1989. PMID: 2683780 Review.
-
Osteoclast biology in the osteopetrotic (op) rat.Am J Anat. 1989 Dec;186(4):325-34. doi: 10.1002/aja.1001860402. Am J Anat. 1989. PMID: 2589217
-
A quantitative histologic study of avian osteopetrotic bone demonstrating normal osteoclast numbers and increased osteoblastic activity.Lab Invest. 1981 Feb;44(2):164-73. Lab Invest. 1981. PMID: 7464041
-
Experimental studies of osteopetrosis in laboratory animals.Clin Orthop Relat Res. 1993 Sep;(294):23-33. Clin Orthop Relat Res. 1993. PMID: 8358920 Review.
-
Osteoclast diseases.Microsc Res Tech. 2003 Aug 15;61(6):514-32. doi: 10.1002/jemt.10375. Microsc Res Tech. 2003. PMID: 12879419 Review.
Cited by
-
Human Genetics of Sclerosing Bone Disorders.Curr Osteoporos Rep. 2018 Jun;16(3):256-268. doi: 10.1007/s11914-018-0439-7. Curr Osteoporos Rep. 2018. PMID: 29656376 Review.
-
Superoxide generation in transformed B-lymphocytes from patients with severe, malignant osteopetrosis.Mol Cell Biochem. 1999 Sep;199(1-2):15-24. doi: 10.1023/a:1006990730115. Mol Cell Biochem. 1999. PMID: 10544947
-
Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.Endocrine. 1999 Dec;11(3):309-19. doi: 10.1385/ENDO:11:3:309. Endocrine. 1999. PMID: 10786828
-
Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.J Clin Invest. 1992 Oct;90(4):1622-7. doi: 10.1172/JCI116032. J Clin Invest. 1992. PMID: 1383278 Free PMC article.
-
Delayed hematopoietic development in osteopetrotic (op/op) mice.J Exp Med. 1993 Jan 1;177(1):237-42. doi: 10.1084/jem.177.1.237. J Exp Med. 1993. PMID: 8418205 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources